Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen Machatha Insider Profile
4 Followers
Stephen Machatha, CDO at Aldeyra Therapeutics, holds 236.77K shares in Aldeyra Therapeutics (Ticker: ALDX). Most recently, Stephen Machatha Sold $16,041 shares of Aldeyra Therapeutics on Aug 14, 2024 for an estimated value of 75.87K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-42.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Stephen Machatha's holdings
Insider Roles
CDO
Roles that Stephen Machatha holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stephen Machatha
Stephen Machatha's Trading History
List of latest transactions for each holding click on a transaction to see Stephen Machatha's performance on stock
You May Also Like
Stephen Machatha insider profile FAQ
What is the percentage of profitable transactions made by Stephen Machatha?
The percentage of profitable transactions made by Stephen Machatha is 0%.
What is the average return per transaction made by Stephen Machatha?
The average return per transaction made by Stephen Machatha is -42.50%.
What stocks does Stephen Machatha hold?
Stephen Machatha holds: ALDX stocks.
What was Stephen Machatha’s latest transaction?
Stephen Machatha latest transaction was an Informative Sell of $75.87K.
What was Stephen Machatha's most profitable transaction?
Stephen Machatha’s most profitable transaction was an Informative Sell of ALDX stock on August 14, 2024. The return on the trade was -11.30%.
What is Stephen Machatha's role in Aldeyra Therapeutics?
Stephen Machatha's role in Aldeyra Therapeutics is CDO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.